Axovia, an innovative gene therapy company developing disease-transformative medicines for ciliopathies, is a majority-owned subsidiary of Jaguar Gene Therapy, which is backed by Deerfield Management and UCL Technology Fund.
AlbionVC leads a £14m Series A investment into Solidatus, next generation data management platform, alongside HSBC Ventures and Citi.
UCL Technology Fund portfolio company Quell Therapeutics, a biotechnology firm developing engineered T regulatory cell therapies, expands Series A financing to $84 Million.
AlbionVC portfolio company Limitless, announces $10m Series B and adds Genesys as a new investor and technology partner to continue US expansion.
Phasecraft, a UCL Technology Fund portfolio company is taking quantum theory from research to reality, faster. Today it announces the largest seed funding round for a UK quantum computing company from a syndicate of new and existing investors.
uMed raises £3.7m in seed financing from AlbionVC and other leading investors to grow its innovative platform, which automates processes in running clinical research registries while ensuring regulatory compliance.
Third Space Learning, an EdTech company backed by the UCL Technology Fund, has secured a £4.3m Series A extension from a syndicate of investors to support expansion to the secondary and international markets.
AlbionVC leads Series A extension investment into WeGift, a digital incentives platform whose clients range from global corporates to SMEs, as it reports 317% annual revenue growth.
